Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Author:
Alig Stefan K.ORCID, Shahrokh Esfahani Mohammad, Garofalo Andrea, Li Michael Yu, Rossi Cédric, Flerlage Tim, Flerlage Jamie E., Adams Ragini, Binkley Michael S., Shukla Navika, Jin Michael C., Olsen Mari, Telenius Adèle, Mutter Jurik A., Schroers-Martin Joseph G.ORCID, Sworder Brian J., Rai Shinya, King Daniel A.ORCID, Schultz Andre, Bögeholz JanORCID, Su ShengqinORCID, Kathuria Karan R., Liu Chih LongORCID, Kang Xiaoman, Strohband Maya J., Langfitt DeannaORCID, Pobre-Piza Kristine Faye, Surman Sherri, Tian FengORCID, Spina Valeria, Tousseyn ThomasORCID, Buedts Lieselot, Hoppe RichardORCID, Natkunam YasodhaORCID, Fornecker Luc-Matthieu, Castellino Sharon M., Advani Ranjana, Rossi Davide, Lynch Ryan, Ghesquières Hervé, Casasnovas Olivier, Kurtz David M.ORCID, Marks Lianna J., Link Michael P., André Marc, Vandenberghe PeterORCID, Steidl ChristianORCID, Diehn MaximilianORCID, Alizadeh Ash A.ORCID
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference81 articles.
1. Sobesky, S. et al. In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection. Med 2, 1171–1193.e11 (2021). 2. Spina, V. et al. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood 131, 2413–2425 (2018). 3. Desch, A. K. et al. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia 34, 151–166 (2020). 4. Vandenberghe, P. et al. Non-invasive detection of genomic imbalances in Hodgkin/Reed–Sternberg cells in early and advanced stage Hodgkin’s lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study. Lancet Haematol. 2, e55–e65 (2015). 5. Kurtz, D. M. et al. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nat. Biotechnol. 39, 1537–1547 (2021).
|
|